drugset / Trial / NCT01896349

Interpersonal Psychotherapy for Treatment Resistant Depression

NCT01896349 ↗

RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to determine whether combination of antidepressant drugs plus interpersonal psychotherapy is superior to antidepressant drugs alone in treatment resistant depression.

Timeline

Start
2013-04
Primary completion
2014-08
Completion
2014-11

Drugs

EvaluationDrugModalityDoseRoute
Background Amitriptyline Small molecule — —
Background Bupropion Small molecule — —
Background Citalopram Small molecule — —
Background Clomipramine Small molecule — —
Background Duloxetine Small molecule — —
Background Escitalopram Small molecule — —
Background Fluoxetine Small molecule — —
Background Fluvoxamine Unknown — —
Background Imipramine Small molecule — —
Background Lithium Unknown — —
Background Mirtazapine Other / unclassified — —
Background Nortriptyline Small molecule — —
Background Paroxetine Small molecule — —
Background Risperidone Other / unclassified — —
Background Sertraline Small molecule — —
Background Sulpiride Small molecule — —
Background Tranylcypromine Small molecule — —
Background Trazodone Small molecule — —
Background Venlafaxine Small molecule — —

Indications

No indication recorded.